In 1983, a cohort study to follow up the family contacts of leprosy cases was implemented in French Polynesia to assess the usefulness and applicability of phenolic glycolipid-I (PGL-I) serology in a leprosy control program. A total of 1201 contacts (666 females, 535 males) have been included in the study. The IgM anti-PGL-I seroprevalence determined on the initial sera was 17%. It was significantly higher among females than males (20% vs 15%, p = 0.02). From 1983 to 1992, 4 out of 204 (2%) anti-PGL-I seropositive contacts developed the disease (1 indeterminate, 1 BT, 1 BL, 1 LL) compared with 10 out of 997 (1%) seronegative contacts (4 indeterminate, 3 BT, 1 BB, 2 TT). Of these 10 patients, only 3 (2 indeterminate, 1 BT) converted to seropositivity when leprosy was diagnosed. The risk of developing leprosy was not significantly higher among seropositive than among seronegative groups (2% vs 1%, p = 0.2). A PGL-I circulating antigen test performed on 216 selected sera at entry into the trial showed a higher antigen prevalence when the antibody level was higher. PGL-I antigen was detectable in 5 of 12 patients tested prior to diagnosis (1 LL, 1 BL, 3 indeterminate). The median time to externalize the disease was not significantly different among antibody-positive and -negative contacts (17 vs 25 months, p = 0.3). The relative risk of developing leprosy for contact individuals was 30.8 times that of noncontacts, and 15% of the total new cases detected between 1983 and 1992 emerged from the study population.(ABSTRACT TRUNCATED AT 250 WORDS)

Download full-text PDF

Source

Publication Analysis

Top Keywords

pgl-i serology
8
family contacts
8
french polynesia
8
1983 1992
8
risk developing
8
developing leprosy
8
leprosy
6
contacts
6
low predictive
4
pgl-i
4

Similar Publications

Long-term storage stability of PGL-I coated ELISA plates for anti-Mycobacterium leprae IgM detection.

J Microbiol Methods

September 2024

Laboratório de Desenvolvimento e Produção de Testes Rápidos, Centro Multiusuário de Pesquisa de Bioinsumos e Tecnologias em Saúde, Instituto de Patologia Tropical e Saúde Pública, Universidade Federal de Goiás, Goiânia, GO 74605-050, Brazil; Innovation Hub in Point of Care Technologies, Universidade Federal de Goiás-Merck S/A. Alliance, 74690-900 Goiânia, GO, Brazil. Electronic address:

The assessment of ELISA plates coated with phenolic glycolipid-I/PGL-I revealed excellent stability during eight years of storage at room temperature, promoting consistent IgM antibody detection in multibacillary leprosy patients. These stable, standardized plates can significantly contribute to efficient leprosy serology research and support its widespread distribution and use in endemic countries.

View Article and Find Full Text PDF

Challenges and advances in serological and molecular tests to aid leprosy diagnosis.

Exp Biol Med (Maywood)

November 2023

Laboratório de Desenvolvimento e Produção de Testes Rápidos, Instituto de Patologia Tropical e Saúde Pública, Universidade Federal de Goiás, Goiânia 74605-050, Brasil.

Leprosy is a neglected chronic infectious disease caused by obligate intracellular bacilli, and . Despite multidrug therapy (MDT) success, leprosy accounts for more than 200,000 new cases yearly. Leprosy diagnosis remains based on the dermato-neurologic examination, but histopathology of skin biopsy and bacilloscopy of intradermal scraping are subsidiary diagnostic tests that require expertise and laboratory infrastructure.

View Article and Find Full Text PDF
Article Synopsis
  • IgM antibodies against phenolic glycolipid I (PGL-I) are important for indicating past infections and the prevalence of leprosy in a population, but they cannot differentiate between recent and past infections.
  • Researchers conducted a serosurvey in leprosy-endemic villages in Bihar, India, using a simple fingerstick blood test to assess anti-PGL-I IgM levels among children aged 3-11 years.
  • The results showed an 11.58% seroprevalence, suggesting a consistent infection rate compared to other areas, highlighting the test's potential as a practical tool for monitoring recent leprosy transmission in children as part of eradication efforts.
View Article and Find Full Text PDF

Introduction: Leprosy, an infectious disease caused by , remains a public health concern in endemic countries, particularly in Brazil. In this study, we conducted an active surveillance campaign in the hyperendemic city of Castanhal in the northeastern part of the state of Pará using clinical signs and symptoms combined with serological and molecular tools to diagnose new cases and to identify drug resistance of circulating strains and their distribution in the community.

Methods: During an active surveillance of one week, we enrolled 318 individuals using three different strategies to enroll subjects for this study: (i) an active survey of previously treated cases from 2006 to 2016 found in the Brazil National Notifiable Disease Information System database ( = 23) and their healthy household contacts (HHC) ( = 57); (ii) an active survey of school children (SC) from two primary public schools in low-income neighborhoods ( = 178), followed by visits to the houses of these newly diagnosed SC ( = 7) to examine their HHC ( = 34) where we diagnosed additional new cases ( = 6); (iii) and those people who spontaneously presented themselves to our team or the local health center with clinical signs and/or symptoms of leprosy ( = 6) with subsequent follow-up of their HHC when the case was confirmed ( = 20) where we diagnosed two additional cases ( = 2).

View Article and Find Full Text PDF
Article Synopsis
  • * A study involving 79 seropositive and 30 seronegative household contacts compared high-resolution ultrasonographic measurements of peripheral nerves, revealing that 26.5% of seropositive contacts showed neural thickening versus only 3.3% of seronegative contacts.
  • * The findings indicate that seropositive contacts are 10.5 times more likely to experience neural impairment, while having a BCG vaccine scar offers significant protection, highlighting the value of incorporating serological and
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!